title: Letter: proton pump inhibitor usage still seems to reduce the risk of high-grade dysplasia and/or oesophageal adenocarcinoma in Barrett's oesophagus--authors' reply.
authors.affiliation: Department of Surgical Gastroenterology L, Aarhus University Hospital, Aarhus, Denmark. frederikhvid@gmail.com.
authors.forename: F
authors.initials: F
authors.lastname: Hvid-Jensen
authors.forename: A M
authors.initials: AM
authors.lastname: Drewes
authors.forename: P
authors.initials: P
authors.lastname: Funch-Jensen
mesh_terms: D000230:Adenocarcinoma / Q000517:prevention & control*; D001471:Barrett Esophagus / Q000188:drug therapy*; D004938:Esophageal Neoplasms / Q000517:prevention & control*; D004947:Esophagus / Q000473:pathology*; D005260:Female; D006801:Humans; D008297:Male; D054328:Proton Pump Inhibitors / Q000627:therapeutic use*
chemical_list: D054328:Proton Pump Inhibitors